MASERA, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 5.685
AS - Asia 3.210
EU - Europa 2.339
SA - Sud America 416
AF - Africa 77
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 11.736
Nazione #
US - Stati Uniti d'America 5.565
SG - Singapore 1.123
CN - Cina 849
HK - Hong Kong 439
RU - Federazione Russa 413
SE - Svezia 350
UA - Ucraina 318
VN - Vietnam 306
BR - Brasile 301
IE - Irlanda 281
DE - Germania 233
IT - Italia 231
GB - Regno Unito 141
IN - India 123
FR - Francia 111
CA - Canada 89
FI - Finlandia 76
AT - Austria 66
KR - Corea 64
BD - Bangladesh 55
NL - Olanda 41
IQ - Iraq 33
AR - Argentina 32
PK - Pakistan 32
ZA - Sudafrica 32
MX - Messico 24
SA - Arabia Saudita 24
TR - Turchia 24
ES - Italia 19
CO - Colombia 18
VE - Venezuela 18
ID - Indonesia 17
PH - Filippine 17
BE - Belgio 16
EC - Ecuador 16
UZ - Uzbekistan 16
JP - Giappone 13
CL - Cile 10
MY - Malesia 9
PL - Polonia 9
EG - Egitto 8
TN - Tunisia 8
AE - Emirati Arabi Uniti 7
CZ - Repubblica Ceca 7
LB - Libano 6
PE - Perù 6
UY - Uruguay 6
AU - Australia 5
AZ - Azerbaigian 5
ET - Etiopia 5
HU - Ungheria 5
IR - Iran 5
JO - Giordania 5
MA - Marocco 5
OM - Oman 5
PY - Paraguay 5
BO - Bolivia 4
IL - Israele 4
KE - Kenya 4
LT - Lituania 4
LY - Libia 4
MN - Mongolia 4
NI - Nicaragua 4
PT - Portogallo 4
AL - Albania 3
BG - Bulgaria 3
DZ - Algeria 3
EU - Europa 3
KG - Kirghizistan 3
KZ - Kazakistan 3
AO - Angola 2
DK - Danimarca 2
GE - Georgia 2
LK - Sri Lanka 2
NP - Nepal 2
PS - Palestinian Territory 2
RO - Romania 2
SN - Senegal 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BB - Barbados 1
BN - Brunei Darussalam 1
CM - Camerun 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GR - Grecia 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
ML - Mali 1
MM - Myanmar 1
MZ - Mozambico 1
RE - Reunion 1
RS - Serbia 1
TH - Thailandia 1
TW - Taiwan 1
Totale 11.736
Città #
Woodbridge 664
Singapore 623
Ann Arbor 558
Ashburn 505
Hong Kong 432
Houston 358
Jacksonville 338
Chandler 329
Fairfield 298
Dublin 270
San Jose 239
Wilmington 147
New York 144
Frankfurt am Main 135
Beijing 122
Princeton 122
Santa Clara 114
Dallas 110
Seattle 103
Chicago 102
Cambridge 98
Hefei 97
Dearborn 95
Ho Chi Minh City 92
Los Angeles 80
The Dalles 71
Nanjing 63
Seoul 62
Hanoi 60
Milan 60
Lawrence 59
Vienna 57
Altamura 55
Fuzhou 55
Lachine 55
Lauterbourg 51
Shanghai 50
Buffalo 34
São Paulo 33
Boardman 27
Munich 27
Nanchang 24
Moscow 23
Changsha 20
Guangzhou 20
Helsinki 19
London 18
San Diego 18
Andover 17
Huizen 17
Jiaxing 17
Lahore 17
Mountain View 17
Council Bluffs 16
Falls Church 16
Dhaka 15
Tianjin 15
Toronto 15
Zhengzhou 15
Johannesburg 12
Shenyang 12
Tashkent 12
Hebei 11
Orem 11
Amsterdam 10
Brussels 10
Haiphong 10
Jeddah 10
Baghdad 9
Brooklyn 9
Da Nang 9
Delhi 9
Denver 9
Jinan 9
Leawood 9
Ningbo 9
Norwalk 9
Ottawa 9
Biên Hòa 8
Chennai 8
Montreal 7
Mumbai 7
Rio de Janeiro 7
Salt Lake City 7
Warsaw 7
Boston 6
Caracas 6
Erbil 6
Guayaquil 6
Istanbul 6
Itajaí 6
Karbala 6
Lissone 6
Monmouth Junction 6
Montevideo 6
Olomouc 6
Porto Alegre 6
Redmond 6
Rome 6
San Mateo 6
Totale 7.642
Nome #
Near infrared spectroscopy (NIRS) as a new non-invasive tool to detect oxidative skeletal muscle impairment in children survived to acute lymphoblastic leukaemia 334
Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting 313
Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia 290
Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia 288
Screening for Coagulopathy and Identification of Children With Acute Lymphoblastic Leukemia at a Higher Risk of Symptomatic Venous Thrombosis: An AIEOP Experience 267
Duration and intensity of maintenance chemotherapy in acute lymphoblastic leukaemia: overview of 42 trials involving 12 000 randomised children 262
Treatment of childhood acute lymphoblastic leukemia in central America: A lower-middle income countries experience 261
Detection of PICALM-MLLT10 (CALM-AF10) and outcome in children with T-lineage acute lymphoblastic leukemia 255
The Controversy of Varicella Vaccination in Children With Acute Lymphoblastic Leukemia 243
Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow 232
Biochemical and genetic defects underlying human congenital hypotransferrinemia 227
The eleventh international childhood acute lymphoblastic leukemia workshop report: Ponte di Legno, Italy, 6-7 may 2009 220
Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy 219
A Childhood Leukaemia Cluster in Milan: Possible Role of Pandemic AH1N1 Swine Flu Virus 218
Possible role of pandemic AH1N1 swine flu virus in a childhood leukemia cluster 218
Role of early diagnosis for a noninvasive treatment of pulmonary thromboembolism in leukemic children 213
Non-conventional therapies in childhood cancer: guidelines for distinguishing non-harmful from harmful therapies: a report of the SIOP Working Committee on Psychosocial Issues in Pediatric Oncology 211
Beneficial and harmful effects of anthracyclines in the treatment of childhood acute lymphoblastic leukaemia: A systematic review and meta-analysis 205
Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster Study Group 205
Skeletal muscle impairment in children after treatment for leukemia. 205
Periodic erythroexchange is an effective strategy for high risk paediatric patients with sickle-cell disease 204
Reconstitution of lymphocyte subpopulations in children with inherited metabolic storage diseases after haematopoietic cell transplantation 200
The Role of Twinning Programs and Telemedicine in Pediatric Oncology in Developing Countries 199
Gene expression profile unravels significant differences between childhood and adult Ph+ acute lymphoblastic leukemia 197
Mechanical and infective central venous catheter-related complications: a prospective non-randomized study using Hickman and Groshong catheters in children with hematological malignancies 194
The seventh international childhood acute lymphoblastic leukemia workshop report: Palermo, Italy, January 29--30, 2005 193
The eighth international childhood acute lymphoblastic leukemia workshop ('Ponte di Legno meeting') report: Vienna, Austria, April 27-28, 2005 192
A new challenge in clinical research in childhood ALL: the prospective meta-analysis strategy for intergroup collaboration 191
Improving outcomes for children with cancer in low-income countries in Latin America: A report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO)-part I 190
Treatment reduction in highly selected standard-risk childhood acute lymphoblastic leukemia. The AIEOP ALL-9501 study 188
Pulses of vincristine and dexamethasone in addition to intensive chemotherapy for children with intermediate-risk acute lymphoblastic leukaemia: a multicentre randomised trial 187
Ponte di Legno Working Group: statement on the right of children with leukemia to have full access to essential treatment and report on the Sixth International Childhood Acute Lymphoblastic Leukemia Workshop 185
GH deficiency in adult B-thalassemia major patients and its relationship with IGF-1 production 184
Ischemic stroke in children treated for acute lymphoblastic leukemia: a retrospective study 180
Income matters: reducing the mortality gap 180
Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemia 179
Communicating with the dying child: An invitation to listening--a report of the SIOP working committee on psychosocial issues in pediatric oncology 178
Role of DNA index in childhood acute lymphoblastic leukemia treated with BFM based therapy: Long term results of the AIEOP-ALL 95 177
Clinical epidemiology of childhood cancer in Central America and Caribbean countries 176
A formulary for pediatric oncology in developing countries 174
Purging iron from the heart 173
Protocol-based treatment for children with cancer in low income countries in Latin America: a report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO)--part II 170
Non-conventional therapies in childhood cancer: Guidelines for distinguishing non-harmful from harmful therapies: A report of the SIOP working committee on psychosocial issues in pediatric oncology 170
Encephalopathy syndrome in children with hemato-oncological disorders is not always posterior and reversible 165
High incidence of erythromycin-resistant Streptococcus pyogenes in Monza (North Italy) in untreated children with symptoms of acute pharyngo- tonsillitis: An epidemiological and molecular study 165
Long term survivors of childhood cancer: Cure and care The Erice Statement 164
Development of lens opacities with peculiar characteristics in patients affected by thalassemia major on chelating treatment with deferasirox (ICL670) at the Pediatric Clinic in Monza, Italy 162
Educational symposium on long-term results of large prospective clinical trials for childhood acute lymphoblastic leukemia (1985-2000) 162
A survey of resources and activities in the MISPHO family of institutions in Latin America: a comparison of two eras 161
Statement by members of the Ponte di Legno Group on the right of children to have full access to essential treatment for acute lymphoblastic leukemia 161
AMOR: a proposed cooperative effort to improve outcomes of childhood cancer in Central America 160
Role of treatment intensification in infants with acute lymphoblastic leukemia: results of two consecutive AIEOP studies 159
Treatment of pediatric non-Hodgkin lymphomas in a country with limited resources: results of the first national protocol in Nicaragua 156
Treatment for children with severe aplastic anemia and sickle cell disease in low income countries in Latin America: a report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO): Part III 146
Degree in medicine: A model of teaching pediatrics in the classroom and in the field 146
All children have a right to full access to treatment for cancer 142
Road Traffic Pollution and Childhood Leukemia: A Nationwide Case-control Study in Italy 131
Prenatal origin of acute lymphoblastic leukaemia in children 127
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood 121
Successful recovery of acute hemosiderotic heart failure in beta-thalassemia major treated with a combined regimen of desferrioxamine and deferiprone 118
Statement by members of the Ponte di Legno group on the right of children with leukemia to have full access to essential treatment for acute lymphoblastic leukemia 100
Totale 11.793
Categoria #
all - tutte 42.448
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.448


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021158 0 0 0 0 0 0 0 0 0 92 25 41
2021/2022545 30 36 47 43 43 38 22 29 48 54 42 113
2022/20231.253 145 376 79 89 103 228 6 61 108 4 34 20
2023/2024744 26 20 28 24 113 215 147 20 56 6 6 83
2024/20251.670 111 248 79 71 169 36 64 82 147 233 151 279
2025/20263.730 327 274 342 355 516 231 562 237 429 457 0 0
Totale 11.793